Can B Corp. income statement NASC

Annual Quarterly

In Q3 of fiscal 2024, the quarter ended Sep 30, 2024, Can B Corp. reported revenue of $15,269, down 96.4% from the same quarter a year earlier. It recorded a net loss of $3.3 million. The operating loss came to $2.8 million, an operating margin of -18553.7%. Diluted earnings per share were -$0.05.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2024	Q3 FY2024 Sep 30, 2024	Q2 FY2024 Jun 30, 2024	Q1 FY2024 Mar 31, 2024	Q4 FY2023 Dec 31, 2023	Q3 FY2023 Sep 30, 2023	Q2 FY2023 Jun 30, 2023	Q1 FY2023 Mar 31, 2023	Q4 FY2022 Dec 31, 2022
Revenue	1 -57.7%	0 -96.4%	0 -35.3%	0 -60.7%	0 -43.4%	0 -85.5%	0 -66.9%	1 -49.5%	1 -66.4%
Cost of revenue	1 -60.8%	0 -66.3%	1 -28.8%	1 +127.5%	-1 -209.4%	1 +20.1%	1 -9.4%	1 -55.9%	1 +11.6%
Gross profit	-0 +67.9%	-0 +51.0%	-0 +23.5%	-1 -298.7%	1 +923.6%	-1 -143.9%	-1 -313.9%	0 -38.1%	-0 -112.4%
Selling, general and administrative	—	2	1	2	—	—	—	—	—
Operating expenses	—	2	1	—	—	—	—	—	—
Operating income	-11 -13.6%	-3 +20.8%	-2 +14.0%	-6 -294.1%	-1 +74.8%	-4 +47.6%	-2 -16.9%	-1 +55.0%	-3 +23.0%
Interest expense	—	0	0	1	—	—	—	—	—
Other non-operating income (expense)	0	0 +129.8%	-0 -100.0%	-0	-0	-0	0 +12961.3%	—	—
Pretax income	-13 -22.5%	-3 +21.7%	-2 -0.1%	-6 -256.3%	-2 +37.7%	-4 +39.6%	-2 -23.2%	-2 +50.4%	-3 +27.8%
Income tax	—	—	—	—	—	0 +100.0%	0 -100.0%	0 +7576.8%	-0
Net income	-13 -22.4%	-3 +21.7%	-2 -0.1%	-6 -254.3%	-2 +37.7%	-4 +39.6%	-2 -23.2%	-2 +50.1%	-3 +27.8%
Basic EPS	-0.29 +82.7%	-0.05 +86.1%	-0.04 +89.2%	-0.16 +55.6%	-0.06 +90.8%	-0.36 +81.8%	-0.37 +24.5%	-0.36 +67.3%	-0.70
Diluted EPS	-0.29	-0.05 +86.1%	-0.04 +89.2%	-0.16	-0.06	-0.36	-0.37	—	—
Weighted average shares, basic	46 +608.5%	65 +464.6%	55 +883.8%	37 +662.8%	28 +578.4%	12 +232.2%	6 +64.8%	5 +55.2%	4
Weighted average shares, diluted	46	65 +464.6%	55 +883.8%	37	28	12	6	—	—
Other measures
Depreciation and amortization	1	0 -100.0%	0 -91.6%	0 -9.4%	0	0	0 -2.8%	0 -3.5%	—
EBITDA	-10	-3 +12.3%	-2 -4.2%	-5 -390.8%	-0	-3	-1 -22.7%	-1 +61.6%	—
Interest coverage	—	-6.59x	-3.38x	-11.17x	—	—	—	—	—
Margins
Gross margin	-33.22%	-2,623.27%	-144.40%	-223.27%	338.16%	-194.93%	-122.17%	44.15%	-23.23%
Operating margin	-1,035.91%	-18,553.67%	-575.50%	-1,532.09%	-172.92%	-854.08%	-433.11%	-152.76%	-388.78%
Pretax margin	-1,282.82%	-21,367.56%	-745.03%	-1,669.26%	-479.20%	-994.23%	-481.94%	-184.12%	-435.18%
Profit margin	-1,282.82%	-21,367.56%	-745.03%	-1,669.26%	-479.20%	-994.23%	-481.94%	-185.14%	-435.30%
EBITDA margin	-969.09%	-18,553.67%	-564.79%	-1,446.90%	-80.84%	-770.96%	-350.89%	-115.83%	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as: NASC (OTC)
Fiscal year ends: December 31
Incorporated in: FL
Headquarters: Hicksville, NY
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1509957
Former names: Canbiola, Inc. (until Mar 3, 2020); Wrapmail, Inc. (until May 15, 2017)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.